...
首页> 外文期刊>Microbial Cell Factories >Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers
【24h】

Multiple copies of the oxytetracycline gene cluster in selected Streptomyces rimosus strains can provide significantly increased titers

机译:选择的链霉菌菌株中的催产素基因簇的多个拷贝可以提供显着增加的滴度

获取原文

摘要

Natural products are a valuable source of biologically active compounds that have applications in medicine and agriculture. One disadvantage with natural products is the slow, time-consuming strain improvement regimes that are necessary to ensure sufficient quantities of target compounds for commercial production. Although great efforts have been invested in strain selection methods, many of these technologies have not been improved in decades, which might pose a serious threat to the economic and industrial viability of such important bioprocesses. In recent years, introduction of extra copies of an entire biosynthetic pathway that encodes a target product in a single microbial host has become a technically feasible approach. However, this often results in minor to moderate increases in target titers. Strain stability and process reproducibility are the other critical factors in the industrial setting. Industrial Streptomyces rimosus strains for production of oxytetracycline are one of the most economically efficient strains ever developed, and thus these represent a very good industrial case. To evaluate the applicability of amplification of an entire gene cluster in a single host strain, we developed and evaluated various gene tools to introduce multiple copies of the entire oxytetracycline gene cluster into three different Streptomyces rimosus strains: wild-type, and medium and high oxytetracycline-producing strains. We evaluated the production levels of these engineered S. rimosus strains with extra copies of the oxytetracycline gene cluster and their stability, and the oxytetracycline gene cluster expression profiles; we also identified the chromosomal integration sites. This study shows that stable and reproducible increases in target secondary metabolite titers can be achieved in wild-type and in high oxytetracycline-producing strains, which always reflects the metabolic background of each independent S. rimosus strain. Although this approach is technically very demanding and requires systematic effort, when combined with modern strain selection methods, it might constitute a very valuable approach in industrial process development.
机译:天然产品是具有医学和农业应用的生物活性化合物的有价值的源。天然产品的一个缺点是确保商业生产足够量的靶化合物所必需的缓慢,耗时的应变改善制度。虽然已经投入了巨大的努力,但在应变选择方法中,这些技术的许多技术数十年来没有得到改善,这可能会对这类重要生物处理的经济和工业活力构成严重威胁。近年来,引入整个生物合成途径的额外副本,其在单个微生物主体中编码目标产品已成为一种技术上可行的方法。然而,这通常导致靶滴度的次要增加。应变稳定性和过程再现性是工业环境中的其他关键因素。工业链霉菌用于生产氧化素的rimosus菌株是最经济的有效菌株之一,因此这些代表了一个非常好的工业案例。为了评估整个基因簇在单个宿主菌株中扩增的适用性,我们开发并评估了各种基因工具,将整个氧化素基因簇的多个拷贝引入三种不同的链霉菌菌株:野生型和中高氧化素 - 产生菌株。我们评估了这些工程化S. rimosus菌株的生产水平,具有额外的含氧杂环素基因簇及其稳定性,以及氧胞素基因簇表达谱的额外副本;我们还确定了染色体一体化位点。该研究表明,靶次级代谢物滴度的稳定和可重复的增加可以在野生型和高氧化胞胞产生的菌株中实现,其总是反映每个独立S. rimosus菌株的代谢背景。虽然这种方法在技术上是非常苛刻的并且需要系统的努力,但在与现代菌株选择方法结合时,它可能构成了工业过程发展中非常有价值的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号